Research
Hormonal
Patients not using semaglutide had a higher 2-year rotator cuff retear rate (18.3% vs 12.5%) compared to those using semaglutide.
This finding suggests that semaglutide may improve long-term surgical outcomes in diabetic patients.
StrongSupportsmedium confidence
(-)semaglutide patients revealed greater 2-year retear vs (+)semaglutide patients (18.3% vs 12.5%, respectively) (P < .001).
Why this rating
Based on the comparative study design with a large sample size.
Source
Lower Risk of Postoperative Complications and Rotator Cuff Retear Associated With Semaglutide Use in Patients with Type II Diabetes Mellitus Undergoing Arthroscopic Rotator Cuff Repair
Anthony E Seddio et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery · 2024
cohort · n=5204Cited 15×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →